Biological ageing diminishes the regenerative capacity of the cardiovascular system. A number of cells have been identified that appear to be responsible for the regeneration of cardiovascular system components including endothelial progenitor cells (EPC), cardiac progenitor cells (CPC) and smooth muscle progenitor cells (SMPC). Recent research seems to confirm the role of biological age in cardiovascular system regeneration. Kajstura et al. have demonstrated that, from 20 to 100 years of age, the pool of cardiomyocytes is replaced 15 times in women and 11 times in men. Paradoxically, cardiomyocyte turnover increases with the biological age of the heart, which probably represents a compensatory mechanism for lower regenerative potential of the cells 1 . Figure 2 presents the role of particular components engaged in cardiovascular system regeneration.
THE EFFECT OF SOME SELECTED RISK FACTORS FOR CARDIOVASCULAR DISEASE ON BIOLOGICAL AGE Diabetes mellitus and oxidative stress
Diabetes mellitus affects the prognosis in the primary and secondary prevention of cardiovascular disease. Risk quantification scores consider diabetes as a coronary heart disease risk equivalent. Salpea et al. demonstrated that type 2 diabetes was associated with shorter leukocyte telomere length (LTL) 2 . It was also observed that diabetes accelerated LTL shortening in patients with a history of myocardial infarction 3 . Moreover, an association was shown between the impaired function of circulating endothelial progenitor cells (EPCs), impaired neovascularisation process and the activation of the p53 signaling pathway 4 . From a molecular perspective, diabetes generates high levels of oxidative stress resulting in cell damage and accelerated ageing.
SHC is an adaptor protein that exists in three isoforms, i.e., p46Shc, p52Shc, and p66Shc. The p66Shc adaptor protein has potential implications for cellular senescence resulting from the induction of mitochondrial oxidation-reduction processes in response to oxidative stress. Reactive oxygen species (ROS) cause damage to nuclear and cytoplasmic structures ultimately resulting in impaired function and apoptosis 5,6 . Thus, potentially dysfunctional cells exposed to oxidative stress are eliminated. ROS formation associated with SHC expression is paradoxically involved in the process. 
THE ROLE OF BIOLOGICAL AGE IN CARDIOVASCULAR DISEASE

BIOLOGICAL AGE AND SECONDARY PREVENTION OF CORONARY HEART DISEASE
So far we have defined biological age, characterised its standard markers, and discussed the effects of some selected risk factors for coronary heart disease on biological age.
Another patient group comprises individuals involved in the programme of secondary preventive therapies for coronary heart disease. Telomere shortening seems to be a primary abnormality in the pathogenesis of coronary heart disease 25 . Reduced LTL is also predictive of increased risk of mortality in patients with stable coronary artery 26,27 . A prospective study of Farzaneh et al. revealed that LTL in patients with stable coronary heart disease may undergo dynamic changes, i.e., may increase, decrease or remain unchanged in patients with stable coronary heart disease 28 . Advanced biological age is also related to the function of vascular endothelium. Satoh et al. demonstrated EPC telomere erosion in CAD, and protective effect of intensive lipid-lowering therapy on endothelial progenitor cell telomeres 29 . Telomere shortening of autopsised coronary endothelial cells of CAD patients was also confirmed 30 . Table 2 presents the role of biological age in the pathogenesis of myocardial infarction, the risk of which is increased in patients with telomere shortening.
Heart failure (HF) is the end-stage of a variety of cardiovascular entities. Enhanced cardiomyocyte apoptosis has been implicated as a pathogenic mechanism underlying the development of HF; the process is associated with fibrosis. Table 1 shows selected research reports confirming the role of biological age advancement in HF. Protein p53 seems to act as a key mediator of HF development. Interestingly, it has been hypothesised that telomere shortening might contribute to higher susceptibility to anaemia in HF patients. An association has also been suggested between biological age and HF severity.
LTL has been show to correlate with the results of echocardiographic examinations. LTL was positively associated with left ventricular mass and wall thickness. Thus, LTL might facilitate the prognosis of left ventricular hypertrophy 31 .
An inverse association of LTL with common carotid artery intimamedia thickness 32,33 and more extensive coronary artery calcification (CAC) 34 has also been found.
SUMMARY
To summarise, in the future biological age may become an important therapy target and therapy determinant. Although there are a multitude of risk factors for coronary heart disease, biological age represents their common molecular denominator.
Therefore the p66Shc gene seems to be of important significance in the pathophysiology of ageing and the development of cardiomyopathy 7 . p66Shc knockout mice display decreased susceptibility to atherosclerotic plaque formation, more efficient endotheliumdependent relaxation, and higher resistance to reperfusion injury associated with oxidative stress 8,9 . Inactivation of the p66Shc gene also protects against age-dependent endothelial dysfunction 10 . Deletion of the p66shc gene in experimental animals with insulindependent diabetes mellitus prevents cardiac progenitor cells from telomeric shortening and limits the accumulation of senescenceassociated proteins p53 and p16INK4. These findings seem to suggest that negative adaptations in the function of cardiac progenitor cells resulting from diabetes-enhanced oxidative stress are among the underlying causes of diabetic cardiomyopathy 11 . Another report indicates a fundamental role of p66Shc in angiotensin II-mediated myocardial remodelling 12 .
Smoking should be emphasised among free-radical generators; the result is oxidative stress. High levels of oxidised-LDL effectively mediate the ageing process 13 , and have been shown to inhibit telomerase activity in endothelial progenitor cells 14 .
Hypertension
The effect of hypertension on biological age has been documented both in human and animal models. It was demonstrated that leukocyte telomere shortening was associated with a higher risk of developing hypertension and, consequently, coronary heart disease 15 . It was also reported that elevated blood pressure increased p16INK4A expression in rat left ventricular cardiomyocytes and cardiac arteries. The level of hypertension-induced p16INK4A protein expression correlated with the severity of left ventricle fibrosis 16 . The role of the renin-angiotensin system in biological senescence has also been investigated. Kunieda et al. demonstrated that angiotensin II induced premature senescence of vascular smooth muscle cells.
The process is probably mediated by angiotensin II receptor type 1 (AT1) 17 whereas the cytoprotective angiotensin II receptor type 2 (AT2) mediated antisenescence signalling 18 . Vasan et al. demonstrated an inversely proportional correlation between renin-to-aldosterone ratio and LTL 19 . Interestingly, increased plasma endothelin-1 levels associated with telomerase deficiency in mice resulted in hypertension 20 .
Gender, physical activity, smoking and lipid disturbances
Due to the fact that women show longer telomeres compared to men, a novel endothelium-associated protective estrogen effect on telomeres has been postulated resulting from de novo synthesis of telomeric DNA, enhanced telomerase activity through human telomerase reverse transcriptase (hTERT) phosphorylation and the production of nitric oxide. 21
Epidemiological evidence has confirmed that physical activity is associated with reduced risk of cardiovascular disease. Exercise also turns out to act as a telomere protecting factor which was confirmed by the analysis of telomere biology of circulating leukocytes in human and animal models 22,23 . Most probably Long-and shortterm physical effort up-regulates telomere-stabilising proteins and prevents cardiomyocyte apoptosis 24 . 
